1. Home
  2. BASE vs LQDA Comparison

BASE vs LQDA Comparison

Compare BASE & LQDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BASE
  • LQDA
  • Stock Information
  • Founded
  • BASE 2011
  • LQDA 2004
  • Country
  • BASE United States
  • LQDA United States
  • Employees
  • BASE N/A
  • LQDA N/A
  • Industry
  • BASE EDP Services
  • LQDA Biotechnology: Pharmaceutical Preparations
  • Sector
  • BASE Technology
  • LQDA Health Care
  • Exchange
  • BASE Nasdaq
  • LQDA Nasdaq
  • Market Cap
  • BASE 834.0M
  • LQDA 856.5M
  • IPO Year
  • BASE 2021
  • LQDA 2018
  • Fundamental
  • Price
  • BASE $15.34
  • LQDA $10.69
  • Analyst Decision
  • BASE Buy
  • LQDA Strong Buy
  • Analyst Count
  • BASE 14
  • LQDA 8
  • Target Price
  • BASE $23.00
  • LQDA $27.14
  • AVG Volume (30 Days)
  • BASE 526.6K
  • LQDA 804.1K
  • Earning Date
  • BASE 12-03-2024
  • LQDA 11-13-2024
  • Dividend Yield
  • BASE N/A
  • LQDA N/A
  • EPS Growth
  • BASE N/A
  • LQDA N/A
  • EPS
  • BASE N/A
  • LQDA N/A
  • Revenue
  • BASE $204,633,000.00
  • LQDA $15,610,000.00
  • Revenue This Year
  • BASE $17.65
  • LQDA N/A
  • Revenue Next Year
  • BASE $15.17
  • LQDA $209.74
  • P/E Ratio
  • BASE N/A
  • LQDA N/A
  • Revenue Growth
  • BASE 19.27
  • LQDA N/A
  • 52 Week Low
  • BASE $13.53
  • LQDA $7.76
  • 52 Week High
  • BASE $32.00
  • LQDA $16.99
  • Technical
  • Relative Strength Index (RSI)
  • BASE 33.99
  • LQDA 46.04
  • Support Level
  • BASE $14.84
  • LQDA $10.77
  • Resistance Level
  • BASE $16.71
  • LQDA $11.32
  • Average True Range (ATR)
  • BASE 0.82
  • LQDA 0.51
  • MACD
  • BASE -0.37
  • LQDA -0.03
  • Stochastic Oscillator
  • BASE 11.79
  • LQDA 16.67

About BASE Couchbase Inc.

Couchbase Inc provides a modern cloud database that offers the robust capabilities required for business-critical applications on a scalable and available platform. It empower developers and architects to build, deploy and run mission-critical applications. Couchbase delivers a high-performance, flexible and scalable modern database that runs across the data center and any cloud. Geographically, the company generates a majority of its revenue from the United States.

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.

Share on Social Networks: